Comparable effect of recombinant and plasma-derived human fibrinogen concentrate on ex vivo clot formation after cardiac surgery.
V
V
Radulovic
F
F
Baghaei
I Fagerberg
IF
Blixter
S
S
Samuelsson
A
A
Jeppsson
D000368:Aged; D001780:Blood Coagulation Tests; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001803:Blood Transfusion; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use*; D006489:Hemostatic Techniques; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013548:Sweden; D013997:Time Factors; D016896:Treatment Outcome
D006490:Hemostatics; D011994:Recombinant Proteins; D005340:Fibrinogen